Drug intelligence / Profile preview

Buckberg Cardi-Braun

Development stage
Unknown
Lead developer
B. Braun
Modality
Small Molecules
Administration
Intracoronary, Intracardiac
01

Overview

Buckberg Cardi-Braun is a specialized cardioplegia solution manufactured by B. Braun, designed for use in the Buckberg protocol for myocardial protection during major cardiac surgery involving extracorporeal circulation. The solution is typically a blood-based cardioplegia, consisting of a mixture of the patient's own blood and a crystalloid concentrate. Its primary mechanism of action involves the induction of rapid, reversible diastolic cardiac arrest through a high concentration of potassium ions, which depolarizes the myocardial cell membrane and prevents electrical and mechanical activity. This state of arrest significantly reduces the heart's oxygen consumption and metabolic demand during the period of aortic cross-clamping. The formulation also includes buffers such as tromethamine (THAM) to counteract ischemia-induced acidosis, and other components like magnesium and dextrose to support metabolic requirements and reduce calcium-mediated injury during the ischemic period and subsequent reperfusion.

Brand names
Buckberg Cardi-BraunCardi-Braun
Other names
Buckberg solutionBuckberg blood cardioplegiaBuckberg cardioplegia solution
02

Targets

Kir (Inward-rectifier potassium channels)

Beyond the preview

Go deeper on Buckberg Cardi-Braun.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Buckberg Cardi-Braun.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call